A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting

Table 3

Rhodes Index of Nausea, Vomiting, and Retching (RINVR) scores among 0.3 mg, 0.45 mg, and 0.6 mg dosing groups at 1 hour, 6 hours, 1 day, 2 days, and 7 days after starting chemotherapy.

	0.3 mg	0.45 mg	0.6 mg
	( = 17)	( = 15)	( = 18)
1 hr	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00
6 hr	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00
1 day	0.78 ± 1.56	0.36 ± 0.93	0.11 ± 0.47
2 days	1.11 ± 2.52	0.79 ± 1.12	0.44 ± 1.34
7 days	3.61 ± 4.80	0.71 ± 1.44	2.39 ± 4.07

Data are presented as mean ± standard deviation.